Johnson & Johnson (NYSE: JNJ) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26 ...

First results from a Phase 3 trial conducted across 25 centers in Japan highlight Ferring’s ongoing commitment to establish ...

First results from a Phase 3 trial conducted across 25 centers in Japan were presented at the Annual Meeting of the Japanese Urological Association ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

The answer turned out to be a cutting-edge treatment that few Americans know about, according to Roswell Park Comprehensive ...

Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...

BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of lung cancer.

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools and flexible CRO models are accelerating oncology trials and improving ...

Right now, you’re being reminded that community isn’t a performance, it’s a practice. And sometimes, that practice looks like letting someone else hold the space for you. Ask for care ...

Anybody who has oral, anal, or vaginal sex, or genital skin-to-skin contact with another person can get STDs — in fact, most sexually active people get one at some point in their life. STDs don’t ...